Pharmaceutical & Healthcare Annual Deals Analysis 2012 (Related Reports)

Pharmaceutical & Healthcare Annual Deals Analysis 2012


February 29, 2012
119 Pages - SKU: GBDT3806262
License type:
Online Download      US $3,500.00
Global Site License      US $10,500.00
EMR 2014: The Market for Electronic Medical Records
4/2/2014 | published by: Kalorama Information
The EMR Industry Standard Kalorama has continuously examined the fast-changing market for electronic medical records (EMR) for nearly a decade, and each year we produce a comprehensive report of our findings.  Our report has become the industry  |  read more...
$3,995.00
Retail Clinics Market Overview and 2014 Survey Results
3/11/2014 | published by: Kalorama Information
Retail Clinics Market Overview and 2014 Survey Results Retail clinics are medical settings located in a retail store. They are not free standing and do not offer all medical  |  read more...
$750.00
Portola Pharmaceuticals, Inc. - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
Portola Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Portola Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Portola Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
$1,500.00
Bone Marrow Transplantation - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Bone Marrow Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bone Marrow Transplantation - Pipeline Review, H1 2014’, provides an overview of the Bone Marrow Transplantation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Cuba Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Cuba Pharmaceuticals and Healthcare Report Q2 2014 BMI View: The Cuban government continues to seek greater foreign investment to help it achieve strongeconomic growth, and is working hard to win the confidence of investors. Many companies  |  read more...
$1,295.00
Silence Therapeutics plc - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
Silence Therapeutics plc - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Silence Therapeutics plc - Product Pipeline Review - 2014’, provides an overview of the Silence Therapeutics plc’s pharmaceutical research and development focus. This report provides  |  read more...
$1,500.00
Moldova Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Moldova Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Despite the geopolitical uncertainty rising from the Russian intervention in Kiev, we believethat Moldova's healthcare and pharmaceutical market will continue to grow in 2014 as the economycontinues  |  read more...
$1,295.00
Johnson & Johnson - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
Johnson & Johnson - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Johnson & Johnson - Product Pipeline Review - 2014’, provides an overview of the Johnson & Johnson’s pharmaceutical research and development focus. This report provides  |  read more...
$1,500.00
Norway Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Norway Pharmaceuticals and Healthcare Report Q2 2014 BMI View: While Norway's reliance on pharmaceutical imports highlights opportunities for drugmakerslooking to export medicines into the country, we note that the Norwegian pharmaceutical market hasdisplayed very slow or  |  read more...
$1,295.00
Slovakia Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Slovakia Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Slovakia generally offers significant potential as a location for pharmaceutical research. This isthanks to its demographic and epidemiological profile, which is broadly similar to Western Europe; EUmembership,  |  read more...
$1,295.00